Sébastien Lepreux, CHU Bordeaux, Hôpital Pellegrin, Service d'Anatomie Pathologique, F-33076 Bordeaux, France.
World J Gastroenterol. 2013 Dec 28;19(48):9343-50. doi: 10.3748/wjg.v19.i48.9343.
To explore this hypothesis that smooth muscle cells may be capable of acquiring a myofibroblastic phenotype, we have studied the expression of smoothelin in fibrotic conditions.
Normal liver tissue (n = 3) was obtained from macroscopically normal parts of hepatectomy, taken at a distance from hemangiomas. Pathological specimens included post-burn cutaneous hypertrophic scars (n = 3), fibrotic liver tissue (n = 5), cirrhotic tissue (viral and alcoholic hepatitis) (n = 5), and hepatocellular carcinomas (n = 5). Tissue samples were fixed in 10% formalin and embedded in paraffin for immunohistochemistry or were immediately frozen in liquid nitrogen-cooled isopentane for confocal microscopy analysis. Sections were stained with antibodies against smoothelin, which is expressed exclusively by smooth muscle cells, and α-smooth muscle actin, which is expressed by both smooth muscle cells and myofibroblasts.
In hypertrophic scars, α-smooth muscle actin was detected in vascular smooth muscle cells and in numerous myofibroblasts present in and around nodules, whereas smoothelin was exclusively expressed in vascular smooth muscle cells. In the normal liver, vascular smooth muscle cells were the only cells that express α-smooth muscle actin and smoothelin. In fibrotic areas of the liver, myofibroblasts expressing α-smooth muscle actin were detected. Myofibroblasts co-expressing α-smooth muscle actin and smoothelin were observed, and their number was slightly increased in parallel with the degree of fibrosis (absent in liver with mild or moderate fibrosis; 5% to 10% positive in liver showing severe fibrosis). In cirrhotic septa, numerous myofibroblasts co-expressed α-smooth muscle actin and smoothelin (more than 50%). In hepatocellular carcinomas, the same pattern of expression for α-smooth muscle actin and smoothelin was observed in the stroma reaction surrounding the tumor and around tumoral cell plates. In all pathological liver samples, α-smooth muscle actin and smoothelin were co-expressed in vascular smooth muscle cells.
During development of advanced liver fibrosis, a subpopulation of myofibroblasts expressing smoothelin may be derived from vascular smooth muscle cells, illustrating the different cellular origins of myofibroblasts.
为了探索平滑肌细胞可能获得成肌纤维细胞表型的假说,我们研究了在纤维化条件下 smoothelin 的表达。
正常肝组织(n = 3)取自肝切除术的大体正常部位,远离血管瘤。病理标本包括烧伤后皮肤肥厚性瘢痕(n = 3)、纤维性肝组织(n = 5)、肝硬化组织(病毒性和酒精性肝炎)(n = 5)和肝细胞癌(n = 5)。组织样本用 10%福尔马林固定,石蜡包埋用于免疫组织化学,或立即用液氮冷却的异戊烷冷冻用于共聚焦显微镜分析。用抗 smoothelin 抗体(平滑肌细胞特异性表达)和抗 α-平滑肌肌动蛋白抗体(平滑肌细胞和肌成纤维细胞共同表达)染色切片。
在肥厚性瘢痕中,α-平滑肌肌动蛋白在血管平滑肌细胞和存在于结节内和周围的许多肌成纤维细胞中被检测到,而 smoothelin 仅在血管平滑肌细胞中表达。在正常肝脏中,血管平滑肌细胞是唯一表达 α-平滑肌肌动蛋白和 smoothelin 的细胞。在肝脏纤维化区域,检测到表达 α-平滑肌肌动蛋白的肌成纤维细胞。观察到共表达 α-平滑肌肌动蛋白和 smoothelin 的肌成纤维细胞,并且它们的数量随着纤维化程度的增加而略有增加(在轻度或中度纤维化的肝脏中不存在;在显示严重纤维化的肝脏中 5%至 10%阳性)。在肝硬化隔中,大量肌成纤维细胞共表达 α-平滑肌肌动蛋白和 smoothelin(超过 50%)。在肝细胞癌中,肿瘤周围基质反应和肿瘤细胞板周围观察到与 α-平滑肌肌动蛋白和 smoothelin 相同的表达模式。在所有病理性肝样本中,α-平滑肌肌动蛋白和 smoothelin 在血管平滑肌细胞中共表达。
在晚期肝纤维化的发展过程中,表达 smoothelin 的肌成纤维细胞亚群可能来自血管平滑肌细胞,说明了肌成纤维细胞的不同细胞来源。